Serum thyroid hormone balance and lipid profile in patients with epilepsy

Epilepsy Research

Volumn 66, Issue 1-3, 2005, Pages 173-183

  Hamed, Sherifa A ^a,c   Hamed, Enas A ^a   Kandil, Mahmoud R ^a   El Shereef, Hala K ^a   Abdellah, Moustafa M ^a   Omar, Hanan ^b  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

^c Saudi German Hospital   (Saudi Arabia)

Author keywords

Antiepileptic drugs; Fasting lipid profile; Lipoproteins; Thyroid hormones

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHOLESTEROL; ENZYME INDUCING AGENT; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME ASSAY; ENZYME INDUCTION; EPILEPSY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

ADULT; AGE FACTORS; ANTICONVULSANTS; CHILD; DEMOGRAPHY; EPILEPSY; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; THYROID HORMONES; THYROTROPIN;

EID: 24744460124     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.08.004     Document Type: Article

References (57)

1. R. Artenie, D. Ungureanu, A. Artenie, G. Botnariu, and E. Anisie HDL-cholesterol - active or passive participant in the pathogenesis of atherosclerosis Rev. Med. Chir. Soc. Med. Nat. Iasi 107 2 2003 282 287
2. A.L. Babson The IMMULITE 2000 Automated Immunoassay System J. Clin. Immunoassay 14 1991 83 88
3. K.D. Bentsen, L. Gram, and A. Veje Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate Acta Neurol. Scand. 67 1983 235 241
4. S.A. Beshyah, A. Henderson, R. Niththyananthan, E. Skinner, V. Anyaoku, W. Richmond, P. Sharp, and D.G. Johnston The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance J. Clin. Endocrinol. Metab. 80 1995 356 363
5. S. Bramswig, A. Kerksiek, T. Sudhop, C. Luers, K. von Bergmann, and H.K. Berthold Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults Am. J. Physiol. Heart Circ. Physiol. 282 2 2002 704 716
6. E.P. Calandre, C. Rodriquez-Lopez, A. Blazquez, and D. Cano Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital Acta Neurol. Scand. 83 4 1991 250 253
7. G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G.K. Hansson Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice Proc. Natl. Acad. Sci. U.S.A. 96 12 1999 6920 6924
8. Z. Canturk, B. Cetinarslan, I. Tarkun, N.Z. Canturk, and M. Ozden Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism Endocr. Res. 29 3 2003 307 316
9. Z. Caparevic, G. Bojkovic, D. Stojanovic, and V. Ilic Dyslipidemia and subclinical hypothyroidism Med. Pregl. 56 5-6 2003 276 280 (Abstract)
10. Commission on Classification and Terminology of the International League Against Epilepsy, 1989. Proposal for revised classification of epilepsies and patients with epilepsy syndromes. Epilepsia 30, 3890-3899.
11. J.M. Connell, W.G. Rapeport, S. Gordon, and M.J. Brodie Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine Eur. J. Clin. Pharmacol. 26 4 1984 453 456
12. G. Deda, H. Caksen, and D. Icagasioglu Effect of long-term carbamazepine therapy on serum lipids, Vitamin B12 and folic acid levels in children J. Pediatr. Endocrinol. Metab. 16 2 2003 193 196
13. M. Deschampheleire, F.H. Luyckx, and A.J. Scheen Thyroid disorders and dyslipidemias Rev. Med. Liege 54 9 1999 746 750
14. Diagnostic Product Corporation, 1987. Albumin-Related Artifacts in Free Thyroid Hormone Assays. Los Angeles.
15. C.P. Earnest, K.A. Wood, and T.S. Church Complex multivitamin supplementation improves homocysteine and resistance to LDL-c oxidation J. Am. Coll. Nutr. 22 5 2003 400 407
16. J.M. Eiris, S. Lojo, M.C. Del Rio, I. Novo, M. Bravo, P. Pavon, and M. Castro-Gago Effects of long-term treatment with antipatients with epilepsy drugs on serum lipid levels in children with epilepsy Neurology 45 6 1995 1155 1157
17. J.M. Eiris-Punal, M. Del Rio-Garma, C. Del Rio-Garma, S. Lojo-Rocamonde, I. Novo-Rodriguez, and M. Castro-Gago Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism Epilepsia 40 1999 1761 1766
18. J. Eiris, M.I. Novo-Rodriguez, M. Del Rio, P. Meseguer, M.C. Del Rio, and M. Castro-Gago The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy Epilepsy Res. 41 1 2000 1 7
19. U.B. Ericsson, I. Bjerre, M. Forsgren, and S.A. Ivarsson Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid Epilepsia 26 6 1985 594 596
20. H. Fichsel, and G. Knpfle Effects of anticonvulsant drugs on thyroid hormones in patients with epilepsy children Epilepsia 19 1978 323 336
21. E. Franzoni, M. Govoni, S. D'Addato, S. Gualandi, Z. Sangiorgi, G.C. Descovich, and G.P. Salvioli Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antipatients with epilepsy drugs Epilepsia 33 5 1992 932 935
22. S.N. Geelen, A.G. Lemmens, A.H. Terpstra, T. Wensing, and A.C. Beynen High density lipoprotein cholesteryl ester metabolism in the pony, an animal species without plasma cholesteryl ester transfer protein activity: transfer of high density lipoprotein cholesteryl esters to lower density lipoproteins and the effect of the amount of fat in the diet Comp. Biochem. Physiol. B Biochem. Mol. Biol. 130 2 2001 145 154
23. A. Goma, S. Abdel-Regal, M. Abdellah, and S. Hamed Monitoring antiepiletptic drug therapy in Upper Egypt: a retrospective 6-years experience in carbamazepine J. Egypt Soc. Pharmacol. Exp. Ther. 25 2 2004 319 335
24. M. Halle, A. Berg, M.W. Baumstark, D. Konig, M. Huonker, and K. Joseph Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels Atherosclerosis 143 1 1999 185 192
25. S.A. Hamed, and T. Nabeshima The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins J. Pharmacol. Sci. 98 4 2005 340 353
26. W.A. Hauser, J.F. Annegers, and L.T. Kurland Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984 Epilepsia 34 1993 453 468
27. L. Hegedus, J.M. Hansen, K. Luhdorf, H. Perrild, U. Feldt-Rasmussen, and J.P. Kampmann Increased frequency of goitre in patients with epilepic patients on long-term phenytoin or carbamazepine treatment Clin. Endocrinol. 23 4 1985 423 429
28. C. Huesca-Gomez, M. Franco, G. Luc, L.F. Montano, F. Masso, C. Posadas-Romero, and O. Perez-Mendez Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat Metabolism 51 4 2002 443 450
29. J.I. Isojarvi, A.J. Pakarinen, A. Rautio, O. Pelkonen, and V.V. Myllyla Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxacarbazepine Epilepsia 35 1994 1217 1220
30. J.I.T. Isojarvi, K.E.J. Airaksinen, and J.N. Mustonen Thyroid and myocardial function after replacing carbamazepine by oxcarbazepine Epilepsia 36 1995 810 816
31. J.I.T. Isojarvi, A.J. Pakarinen, and V.V. Myllyla Thyroid function in patients with epilepsy patients treated with carbamazepine Arch. Neurol. 46 1989 1175 1178
32. J.I.T. Isojarvi, A.J. Pakarinen, P.J. Ylipalosaari, and V.V. Myllyla Serum hormones in male patients with epilepsy patients receiving anticonvulsant medication Arch. Neurol. 47 1990 670 676
33. J.I. Isojarvi, J. Turkka, A.J. Pakarinen, M. Kotila, J. Rattya, and V.V. Myllyla Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy Epilepsia 42 2001 930 934
34. I. Jouko, T. Isojarvi, J. Turkka, A.J. Pakarinen, M. Kotila, J. Ruttyu, and S. Kawashima Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis J. Pharmacol. Sci. 4 2004 411 419
35. P. Klosterskov Jensen, V. Saano, P. Haring, B. Svenstrup, and G.P. Menge Possible interaction between oxcarbazepine and an oral contraceptive Epilepsia 33 1992 1149 1152
36. J.G. Larkin, P.J. McKee, G. Forrest, G.H. Beastall, B.K. Park, J.I. Lowrie, P. Lloyd, and M.J. Brodie Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects Br. J. Clin. Pharmacol. 31 1991 65 71
37. K. Liewendahl, H. Majuri, and T. Helenius Thyroid function test in patients on long-term treatment with various anticonvulsant drugs Clin. Endocrinol. 8 1978 185 191
38. P.V. Luoma, V.V. Myllyla, E.A. Sotaniemi, I.A. Lehtinen, and E.J. Hokkanen Plasma high-density lipoprotein cholesterol in patients with epilepsys treated with various anticonvulsants Eur. Neurol. 19 1 1980 67 72
39. P.V. Luoma, V.V. Myllyla, and E. Hokkanen Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in patients with epilepsys J. Cardiovasc. Pharmacol. 4 6 1982 1024 1027
40. M.A. Mishkel, and S.M. Crowther Hypothyroidism, an important cause of reversible hyperlipidemia Clin. Chim. Acta 74 2 1977 139 151
41. J.P. Monson, R. Abs, B.A. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Stahl, M. Thoren, B. Westberg, P. Wilton, and C. Wuster Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database Clin. Endocrinol. 53 2000 281 289
42. E. Pita-Calandre, C.M. Rodriguez-Lopez, M.D. Cano, and M. Pena-Bernal Serum lipids, lipoproteins, and apolipoproteins in adult patients with epilepsys treated with carbamazepine, valproic acid, or phenytoin Rev. Neurol. 27 159 1998 785 789
43. P.B. Pritchard Hyposexuality: a complication of complex partial epilepsy Trans. Am. Neurol. Assoc. 105 1980 193 195
44. A.W. Rettenmeier, W.N. Howald, R.H. Levy, D.J. Witek, W.P. Gordon, D.J. Porubek, and T.A. Baillie Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques Biomed. Environ. Mass Spectrom. 18 3 1989 192 199
45. T. Rosen, S. Eden, G. Larson, L. Wilhelmsen, and B.A. Bengtsson Cardiovascular risk factors in adult patients with growth hormone deficiency Acta Endocrin. 129 1993 195 200
46. J. Spacilova, Z. Limanova, and M. Aschermann Subclinical hypothyroidism with emphasis on the cardiovascular system Cas. Lek. Cesk. 142 11 2003 643 647 (Abstract)
47. R.E. Strandjord, S. Aanderud, O.L. Myking, and S.I. Johannessen Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy Acta Neurol. Scand. 63 1981 111 121
48. T. Sudhop, J. Bauer, C.E. Elger, and K. von Bergmann Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study Epilepsia 40 4 1999 480 484
49. M.I. Surks, and C.R. DeFesi Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine JAMA 275 1996 149 158
50. L. Tumer, A. Serdaroglu, A. Hasanoglu, G. Biberoglu, and E. Aksoy Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in patients with epilepsy children taking anticonvulsants Acta Paediatr. 91 9 2002 923 926
51. A. Verrotti, F. Basciani, S. Domizio, G. Sabatino, G. Morgese, and F. Chiarelli Serum lipids and lipoproteins in patients treated with antipatients with epilepsy drugs Pediatr. Neurol. 19 5 1998 364 367
52. A. Verrotti, F. Basciani, S. Morresi, G. Morgese, and F. Chiarelli Thyroid hormones in patients with epilepsy children receiving carbamazepine and valproic acid Pediatr. Neurol. 25 2001 43 46
53. S.M. Villa, and N.M. Alexander Carbamazepine (Tegretol) inhibits in vivo iodide uptake and hormone synthesis in rat thyroid glands Endocr. Res. 13 1987 385 397
54. M. Weissel Possible consequences of subclinical hypothyroidism Acta Med. Austriaca 30 4 2003 93 97 (Abstract)
55. L.R. Witherspoon, A.S. el Shami, S.E. Shuler, H. Neely, R. Sonnemake, S.S. Gilbert, and K. Alyea Chemically blocked analog assays for free thyronines. I. The effect of chemical blockers on T4 analog and T4 binding by albumin and by thyroxin-binding globulin Clin. Chem. 34 1988 9 16
56. E. Yilmaz, Y. Dosan, M.K. Gurgoze, and S. Gungor Serum lipid changes during anticonvulsive treatment serum lipids in patients with epilepsy children Acta Neurol. Belg. 101 4 2001 217 220
57. J.H. Yoo, and S.B. Hong A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in patients with epilepsy patients receiving anticonvulsants Metabolism 48 8 1999 1047 1051